top of page

1 July 2019

Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy.

Access this peer-reviewed publication here:

https://doi.org/10.1530/EC-19-0272

We Acknowledge the Traditional Custodians of the Lands and Waterways on which we work and pay our respects to Aboriginal and Torres Strait Islander Elders, past and present. Sovereignty was never ceded. This always was, and always will be, Aboriginal land. All information provided on this website is intended as a guide only. Please see your doctor for specific health advice for your individual circumstances. © 2026 Trans Health Research.

bottom of page